Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Therapy of Nebulized 3% Hypertonic Saline and Chest Percussion Therapy in Pediatric Patients With Acute Viral Bronchiolitis
NCT06441162Phase 4Terminated
- Sponsor
- NYU Langone Health
- Start
- Jul 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium chloride in acute bronchiolitis (2 arms), sponsored by NYU Langone Health. Primary endpoints: Length of Hospital Stay and Time on Supplemental Oxygen Support. Started Jul 2024; status: terminated.
02
Drugs
sodium chloride
03
Conditions
acute bronchiolitis
Beyond the preview
Go deeper on NCT06441162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06441162.